Researchers advance glioblastoma studies through gene therapy and cell mapping

New scientific developments are targeting glioblastoma, an aggressive and common malignant brain tumor. A research team led by Roger Abounader at the University of Virginia is investigating an experimental ultrasound-based gene therapy. This method uses MRI-guided focused ultrasound to temporarily open the blood-brain barrier via microscopic bubbles, allowing nanoparticles carrying microRNAs to reach tumor sites. Preclinical testing in animal models showed reduced tumor growth and extended survival, potentially offering a less toxic alternative to traditional chemotherapy.

In a separate study, scientists from the Wellcome Sanger Institute, the European Molecular Biology Laboratory, and the German Cancer Research Center mapped over one million cells to create the GBM-Space atlas. This multiomic atlas reveals that glioblastoma cells follow predictable structural patterns and developmental trajectories rather than random growth. By identifying the gene regulators that drive these transitions, researchers hope to develop drugs that target early-stage cancer cells before they become resistant to treatment.